Laul, E., Gosselé, K., Matter, C. M., Liu, W.-H. W., González, J. A., Holland, J. P., … Nevado, C. (2026). Balancing Stability and Payload Release in Glutathione-Responsive PROTAC Prodrugs Targeting Prostate Cancer. Journal of the American Chemical Society Au, 6(7), 3816–3827. https://doi.org/10.1021/jacsau.6c00397

Gosselé, K., Latino, I., Laul, E., Kirillova, M. S., Pascanu, V., Carloni, E., … Nevado, C. (2025). Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation. Journal of the American Chemical Society Au, 5, 2491-2499. https://doi.org/10.1021/jacsau.5c00085

Cheng-Sánchez, I., Gosselé, K., Palaferri, L., Laul, E., Riccabella, G., Bedi, R. K., … Nevado, C. (2024). Structure-based design of CBP/EP300 degraders: when cooperativity overcomes affinity. Journal of the American Chemical Society Au, 4(9), 3466-3474. https://doi.org/10.1021/jacsau.4c00292 (Original work published)

Dolbois, A., Batiste, L., Wiedmer, L., Dong, J., Brütsch, M., Huang, D., … Caflisch, A. (2020). Hitting a moving target: simulation and crystallography study of ATAD2 bromodomain blockers. ACS Medicinal Chemistry Letters, 11(8), 1573-1580. https://doi.org/10.1021/acsmedchemlett.0c00080 (Original work published)